Spoken Alpha
IDYA
IDEAYA Biosciences, Inc.
Overview
IDEAYA Biosciences, Inc is a Healthcare company operating in Biotechnology with a $3.28B market cap.
Most recent reported earnings: Q3 FY2026 (Nov 2, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-10-04.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q3 FY20262026-11-02EPS— vs $-1.28—Rev— vs ——EODHD
- Q2 FY20262026-08-03EPS$-1.22 vs $-1.18-3.4%Rev$8.9M vs ——EODHD
- Q1 FY20262026-05-04EPS$-1.11 vs $-0.98-13.3%Rev$6.6M vs ——EODHD
- Q4 FY20252026-02-16EPS$-0.94 vs $-0.95+1.1%Rev$10.9M vs ——EODHD
- Q3 FY20252025-11-03EPS$1.33 vs $-0.55+100.0%Rev$207.8M vs ——EODHD
- Q2 FY20252025-08-04EPS$-0.88 vs $-0.79-11.4%Rev$0 vs ——EODHD
- Q1 FY20252025-05-05EPS$-0.82 vs $-0.69-18.8%Rev$0 vs ——EODHD
- Q4 FY20242025-02-17EPS$-1.49 vs $-0.62-100.0%Rev$7.0M vs ——EODHD
- Q3 FY20242024-11-04EPS$-0.60 vs $-0.63+4.8%Rev$0 vs ——EODHD
- Q2 FY20242024-08-05EPS$-0.68 vs $-0.53-28.3%Rev$0 vs ——EODHD
- Q1 FY20242024-05-06EPS$-0.53 vs $-0.50-6.0%Rev$0 vs ——EODHD
- Q4 FY20232024-02-19EPS$-0.52 vs $-0.46-13.0%Rev$3.9M vs ——EODHD
- Q3 FY20232023-11-06EPS$-0.46 vs $-0.50+8.0%Rev$8.0M vs ——EODHD
- Q2 FY20232023-08-09EPS$-0.50 vs $-0.55+9.1%Rev$3.5M vs ——EODHD
- Q1 FY20232023-05-08EPS$-0.49 vs $-0.54+9.3%Rev$7.9M vs ——EODHD
- Q4 FY20222023-03-06EPS$-0.50 vs $-0.56+10.7%Rev$4.0M vs ——EODHD
- Q3 FY20222022-11-07EPS$0.04 vs $-0.62+100.0%Rev$29.7M vs ——EODHD
- Q2 FY20222022-08-14EPS$-0.57 vs $-0.51-11.8%Rev$5.9M vs ——EODHD
- Q1 FY20222022-05-09EPS$-0.36 vs $-0.42+14.3%Rev$11.4M vs ——EODHD
- Q4 FY20212022-03-14EPS$-0.47 vs $-0.31-51.6%Rev$3.0M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-02 | — | $-1.28 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-03 | $-1.22 | $-1.18 | -3.4% | $8.9M | — | — | EODHD |
| Q1 FY2026 | 2026-05-04 | $-1.11 | $-0.98 | -13.3% | $6.6M | — | — | EODHD |
| Q4 FY2025 | 2026-02-16 | $-0.94 | $-0.95 | +1.1% | $10.9M | — | — | EODHD |
| Q3 FY2025 | 2025-11-03 | $1.33 | $-0.55 | +100.0% | $207.8M | — | — | EODHD |
| Q2 FY2025 | 2025-08-04 | $-0.88 | $-0.79 | -11.4% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-05 | $-0.82 | $-0.69 | -18.8% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-02-17 | $-1.49 | $-0.62 | -100.0% | $7.0M | — | — | EODHD |
| Q3 FY2024 | 2024-11-04 | $-0.60 | $-0.63 | +4.8% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-05 | $-0.68 | $-0.53 | -28.3% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-06 | $-0.53 | $-0.50 | -6.0% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-02-19 | $-0.52 | $-0.46 | -13.0% | $3.9M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $-0.46 | $-0.50 | +8.0% | $8.0M | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.50 | $-0.55 | +9.1% | $3.5M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.49 | $-0.54 | +9.3% | $7.9M | — | — | EODHD |
| Q4 FY2022 | 2023-03-06 | $-0.50 | $-0.56 | +10.7% | $4.0M | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $0.04 | $-0.62 | +100.0% | $29.7M | — | — | EODHD |
| Q2 FY2022 | 2022-08-14 | $-0.57 | $-0.51 | -11.8% | $5.9M | — | — | EODHD |
| Q1 FY2022 | 2022-05-09 | $-0.36 | $-0.42 | +14.3% | $11.4M | — | — | EODHD |
| Q4 FY2021 | 2022-03-14 | $-0.47 | $-0.31 | -51.6% | $3.0M | — | — | EODHD |
Source: EODHD. IDYA reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Yujiro S HataCEO7 yr 6 mo1 callCurrent
- Joshua BleharskiCFO1 yr 5 mono recorded callsCurrent
- Theodora RossChief Development Officer8 mono recorded callsCurrent
- Stuart DormanChief Commercial Officer1 yr 11 mono recorded callsCurrent
- Michael Anthony WhiteChief Scientific Officer3 yr 9 mono recorded callsCurrent
- Darrin BeaupreChief Medical Officer3 yr 9 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for IDYA.
$ curl https://api.spokenalpha.com/v1/companies/IDYAFAQ
Frequently asked about IDYA
Where can I find IDEAYA Biosciences, Inc.'s (IDYA) earnings call transcripts?
Spoken Alpha indexes IDYA's earnings call transcripts at https://spokenalpha.com/companies/IDYA. Each call links to attributed speakers and parsed analyst Q&A. IDEAYA Biosciences, Inc.'s own investor relations page is at https://ir.ideayabio.com/.
When was IDEAYA Biosciences, Inc.'s most recent earnings call?
IDEAYA Biosciences, Inc. (IDYA) held its most recent earnings call on 2022-03-15, covering fiscal Q4 2021.
What sector is IDYA in?
IDEAYA Biosciences, Inc. (IDYA) operates in the Healthcare sector (Biotechnology industry).